# Summary of Tariff Suspensions and Reductions Document
This document is a section of U.S. tariff legislation that adds new duty suspensions and reductions to the Harmonized Tariff Schedule of the United States. It contains 120 new tariff items (numbered 9902.19.01 through 9902.20.24) that provide temporary duty-free or reduced-duty status for various goods.
Key features of the document:
1. **Content**: The list includes chemical compounds, food ingredients, and specialty materials (such as shelled pine nuts, licorice extract, refined carrageenan, various chemicals like neodymium metal, tungsten concentrate, and numerous organic compounds).
2. **Tariff Treatment**: Most entries are listed as "Free" (meaning duty-free), with a few having small duty rates (e.g., 0.7%, 1.8%, 2.3%, 2.9%, 4.3%).
3. **Effective Period**: All listed suspensions and reductions are effective "On or before 12/31/2025."
4. **Purpose**: These tariff suspensions are intended to support specific industries, reduce costs for manufacturers, or provide temporary relief for certain imported goods.
5. **Technical Details**: Each entry includes the chemical name, CAS number, Harmonized Tariff Schedule code, duty rate, and a brief description of the product.
This document represents a legislative amendment to the Harmonized Tariff Schedule, specifically adding new subchapter II of chapter 99 to provide temporary duty relief for these specific items.
The Essential Caregivers Act of 2024 requires nursing homes and similar facilities to allow residents to designate essential caregivers who provide emotional support or assistance with daily activities. During emergencies when regular visitation is restricted, facilities must permit at least one essential caregiver access to residents daily and cannot deny access without following specific procedures. Facilities may deny access for a maximum of 7 days during emergencies (or 14 days with state approval), and must provide a written explanation and appeal process if access is denied. The bill establishes a 48-hour appeal process for residents and caregivers to challenge denials, with facilities required to prove violations during appeals. This law applies to Medicare skilled nursing facilities, Medicaid nursing facilities, intermediate care facilities, and certain inpatient rehabilitation facilities.
HR 8260, the Hospital Inpatient Services Modernization Act, extends the Medicare waiver program allowing acute hospital care at home through 2029 (previously set to expire in 2024). The bill requires the Secretary of Health and Human Services to conduct two separate studies on this program: one by September 2024 and another by September 2028. The second study must specifically compare care quality, outcomes, and costs between patients entering the program directly from an emergency department versus those transitioning from an existing inpatient hospital stay. This bill directly affects Medicare beneficiaries eligible for the Acute Hospital Care at Home initiative and mandates federal evaluation of the program's impact on different patient pathways.
HR 8018, the ABC Act, requires Medicare, Medicaid, CHIP, and Social Security Administration to review their eligibility processes, forms, and communications to simplify interactions for family caregivers. It targets reducing duplicate paperwork, improving website accessibility (including ADA compliance), and enhancing staff communication - such as shorter call waits and multilingual support - to better serve caregivers supporting individuals enrolled in these programs. The review must include input from caregivers and organizations, with results reported to Congress within one year. This procedural bill does not change program benefits but mandates systemic improvements to reduce administrative burdens.
HR 7927, the Pink Tariffs Study Act, requires the Treasury Secretary to conduct a study analyzing how U.S. import tariffs impact different consumer groups. The study must examine whether tariffs disproportionately burden basic goods (like mass-market items) versus luxury items, assess potential gender-based tariff biases (such as higher rates on women’s clothing), and break down these effects by gender, household type, and income level. It does not change current tariff rates but mandates a detailed analysis of how tariff costs fall unequally across consumers. The study must be completed within one year of the bill’s enactment and submitted to Congress.
The Telehealth Modernization Act of 2024 extends Medicare's temporary telehealth coverage rules permanently, removing the previous 2024 expiration date. It expands who can provide telehealth services by allowing more healthcare professionals (like certain nurse practitioners) to bill Medicare for these services, and ensures Federally Qualified Health Centers and Rural Health Clinics can continue billing for telehealth under existing payment rules after 2024. The bill also explicitly permits audio-only telehealth calls for Medicare coverage and allows telehealth for hospice face-to-face visits and home dialysis assessments as clinically appropriate, without time limits. These changes directly affect Medicare beneficiaries, healthcare providers, and community health centers offering telehealth services.
This bill requires Medicare to cover falls risk assessments and fall prevention services during annual wellness visits and initial preventive physical exams for seniors aged 65+ who have fallen in the previous year. It directly affects Medicare beneficiaries with recent falls and healthcare providers delivering these services under Medicare. The key mechanism expands existing Medicare benefits to include these specific fall prevention services, effective January 1, 2025. Additionally, it mandates annual reports starting in 2026 tracking falls data for seniors over 65 who received fall-related treatment.
This bill amends Medicare rules to expand eligibility for rural emergency hospitals. It changes the timeframe during which hospitals can qualify for this specific Medicare reimbursement status, allowing facilities to meet eligibility requirements at any point from January 1, 2015, onward. The change directly affects rural hospitals seeking to become designated Medicare rural emergency hospitals to receive appropriate federal funding. This is a technical adjustment to Medicare eligibility rules, not a new funding program.
The Prescription Drug Supply Chain Pricing Transparency Act requires the Government Accountability Office (GAO) to study how compensation and payment structures affect prescription drug prices within the supply chain. The GAO will examine how intermediaries like pharmacy benefit managers, drug wholesalers, and manufacturers set fees based on drug prices - including potential conflicts of interest - and analyze trends over time. This study must be completed within two years, with findings and recommendations submitted to Congress. The bill does not change current laws but aims to increase transparency for future policy decisions.
HR 7555, the RETRO GSP Act, requires the U.S. government to refund over $3 billion in tariffs paid by American businesses on imports from beneficiary countries during the GSP program's lapse (Dec 31, 2020-enactment date). It directs U.S. Customs to retroactively treat qualifying import entries as if they occurred on Dec 31, 2020, allowing businesses to get tariff refunds. Companies must submit refund requests to Customs within 180 days of the bill's enactment, with payments due within 90 days of processing. This directly affects U.S. importers of goods from GSP-eligible countries who paid duties during the program's suspension.
HR 7427 clarifies that states may use Temporary Assistance for Needy Families (TANF) funds to support pregnancy centers and other "alternatives to abortion" programs that provide life-affirming services like counseling, parenting resources, and material support to pregnant individuals. The bill explicitly defines these programs as those promoting childbirth over abortion through services such as prenatal care coordination, job training, infant supplies, and adoption referrals, while excluding entities that provide or facilitate abortions. It also prohibits federal discrimination against grantees or states that fund such programs, including preventing the government from imposing unfair requirements or cutting funding based on a provider's opposition to abortion. This bill directly affects pregnancy centers, adoption agencies, and maternity homes receiving TANF funding, ensuring their eligibility under existing federal law. The legislation responds to a 2023 federal proposal that threatened to restrict such funding.
This bill requires Medicare to provide clear outreach and education so Medicare beneficiaries (enrolled in Part A, Part B, or Medicare Advantage plans) can authorize family caregivers to access their health information via 1-800-MEDICARE. It mandates the inclusion of a specific authorization form (CMS-10106) in Medicare notices and on Medicare.gov, along with training for call center staff. The Secretary must also share best practices to prevent fraud related to caregiver access and make materials available in non-English languages. It directly affects beneficiaries, their family caregivers, healthcare providers, and Medicare call center operators.
